UA91183U - Method for treating cognitive disorders in patients with dyscirculatory encephalopathy stage ii - Google Patents

Method for treating cognitive disorders in patients with dyscirculatory encephalopathy stage ii

Info

Publication number
UA91183U
UA91183U UAU201400467U UAU201400467U UA91183U UA 91183 U UA91183 U UA 91183U UA U201400467 U UAU201400467 U UA U201400467U UA U201400467 U UAU201400467 U UA U201400467U UA 91183 U UA91183 U UA 91183U
Authority
UA
Ukraine
Prior art keywords
patients
stage
cognitive disorders
treating cognitive
dyscirculatory encephalopathy
Prior art date
Application number
UAU201400467U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Наталія Володимирівна Литвиненко
Галина Ярославівна Силенко
Вікторія Анатоліївна Пінчук
Анжеліна Михайлівна Кривчун
Original Assignee
Наталія Володимирівна Литвиненко
Галина Ярославівна Силенко
Вікторія Анатоліївна Пінчук
Анжеліна Михайлівна Кривчун
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Наталія Володимирівна Литвиненко, Галина Ярославівна Силенко, Вікторія Анатоліївна Пінчук, Анжеліна Михайлівна Кривчун filed Critical Наталія Володимирівна Литвиненко
Priority to UAU201400467U priority Critical patent/UA91183U/en
Publication of UA91183U publication Critical patent/UA91183U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The method for treating the cognitive disorders in the patients with dyscirculatory encephalopathy stage II provides for the conventional therapy comprising neuroprotectors, antiaggregants, peripheral vasodilatators and infusion therapy. In addition, Mema composition is used at a dose of 10 mg once a day for 2 months.
UAU201400467U 2014-01-20 2014-01-20 Method for treating cognitive disorders in patients with dyscirculatory encephalopathy stage ii UA91183U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201400467U UA91183U (en) 2014-01-20 2014-01-20 Method for treating cognitive disorders in patients with dyscirculatory encephalopathy stage ii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201400467U UA91183U (en) 2014-01-20 2014-01-20 Method for treating cognitive disorders in patients with dyscirculatory encephalopathy stage ii

Publications (1)

Publication Number Publication Date
UA91183U true UA91183U (en) 2014-06-25

Family

ID=56282941

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201400467U UA91183U (en) 2014-01-20 2014-01-20 Method for treating cognitive disorders in patients with dyscirculatory encephalopathy stage ii

Country Status (1)

Country Link
UA (1) UA91183U (en)

Similar Documents

Publication Publication Date Title
MX2021004828A (en) Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy.
PH12019500521A1 (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
MX2017002271A (en) Compositions and methods for treatment of neurological disorders.
MY187540A (en) Compounds active towards bromodomains
SG10201808053XA (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
MX2017014338A (en) Targeted selection of patients for treatment with cortistatin derivatives.
WO2019006005A3 (en) Methods and compositions for treating melanoma
TW201613919A (en) Inhibitors of Bruton's tyrosine kinase
MX2021009899A (en) Administration and dosage of diaminophenothiazines.
MX2019015676A (en) Use of isovalerylspiramycin i, ii and/or iii in preparation of drug for treating and/or preventing tumour, and drug.
MX2015012322A (en) Use of levocetirizine and montelukast in the treatment of autoimmune disorders.
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2018010223A (en) Combination therapy for treatment of ovarian cancer.
PH12021551138A1 (en) Application of chidamide in combination with r-chop, and drug combination
UA91183U (en) Method for treating cognitive disorders in patients with dyscirculatory encephalopathy stage ii
MX2018011512A (en) Use of insulin for promoting gastric emptying.
MX2017011838A (en) Compositions and methods for treating hepatocellular carcinoma.
UA103632U (en) Method for complex treatment of patients with anxious depression
PH12016502113A1 (en) Drug for treatment of tinnitus patients
UA93428U (en) Method for treating high grade of lipidemia
UA75277U (en) Method for treating dystrophic diseases of retina and choroid
UA100661U (en) Method for increasing efficacy of treatment of non-calculous cholecystitis in the setting of metabolic syndrome
UA104614U (en) A method of treating chronic toxocarosis combined with enterobioze adults